Venous thrombotic risk related to SARS-CoV-2: prevalence, recommendations and perspectives
Revue Medicale Suisse
; 16(692):951-954, 2020.
Article
in French
| EMBASE | ID: covidwho-1870393
ABSTRACT
Since the SARS-CoV-2 pandemic outbreak, growing evidence suggests that patients suffering from COVID-19 are at increased risk of thrombotic events. The sepsis-related activation of the coagulation combined with a high prevalence of common thrombotic risk factors could contribute to this prothrombotic state. Coagulation biomarkers could help in the identification of patients at risk of complications and mortality. The incidence of venous thromboembolic events appears to be increased, especially in severe COVID-19 patients. Based on that knowledge, several societies have provided recommendation on the prevention of venous thromboembolism. In this narrative review, we summarize available epidemiologic data on venous thromboembolism and recommendations on thromboprophylaxis in COVID-19.
adult; article; complication; controlled study; coronavirus disease 2019; human; incidence; mortality; narrative; nonhuman; organization; pandemic; prevalence; prevention; risk assessment; risk factor; sepsis; Severe acute respiratory syndrome coronavirus 2; thrombosis; thrombosis prevention; vein embolism; vein thrombosis; venous thromboembolism; biological marker
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Observational study
/
Prognostic study
Language:
French
Journal:
Revue Medicale Suisse
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS